Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)
- Authors:
- Yuxin Xie
- Qiyan Deng
- Menglu Guo
- Xiaolong Li
- Deihai Xian
- Jianqiao Zhong
-
Affiliations: Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Neurobiology, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China - Published online on: May 9, 2023 https://doi.org/10.3892/etm.2023.11999
- Article Number: 300
-
Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Wang K, Sun X, Cao Y, Dai L, Sun F, Yu P and Dong L: Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study. Medicine (Baltimore). 97(e12520)2018.PubMed/NCBI View Article : Google Scholar | |
|
Chimenz R, Cannavò L, Spinuzza A, Fede C, Cucinotta U, Pensabene L, Betta P, Gitto E, Concolino D and Cuppari C: Unusual presentation of Henoch-Schönlein purpura. J Biol Regul Homeost Agents. 33 (5 Suppl 1):S69–S74. 2019.PubMed/NCBI | |
|
Gómez S, Pérez M, Pellegrini M, Isern E, Quintana C, Artacho P, Bertolini M, Pomerantz B and Gadda N: Henoch-Schonlein purpura in pediatrics: Ten years of experience at a moderate risk office of a general hospital. Arch Argent Pediatr. 118:31–37. 2020.PubMed/NCBI View Article : Google Scholar : (In English, Spanish). | |
|
Yang HR: What we know about Henoch-Schönlein purpura in children up to date? J Korean Med Sci. 33(e199)2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, Dong Y, Wu L and Deng F: Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children. BMC Pediatr. 19(409)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang N, Guo PJ, Liu PL, Yang HR, Xiao J, Li XP, Huang JB and Zheng YZ: Comparison of age-based clinical and abnormal immune parameters in patients with Henoch-Schönlein purpura. Zhonghua Xue Ye Xue Za Zhi. 38:60–64. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Niknam N, Ha L and Gautam-Goyal P: Adult onset immunoglobulin A vasculitis (Henoch-Schonlein purpura) with alveolar hemorrhage. IDCases. 12:47–48. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Tan J, Tang Y, Zhong Z, Yan S, Tan L, Tarun P and Qin W: The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis. Int Urol Nephrol. 51:975–985. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Roman C, Dima B, Muyshont L, Schurmans T and Gilliaux O: Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): Case series and a review of the literature. Eur J Pediatr. 178:1275–1281. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Vonend C, Rifkin SI, Baliga RS and Weinstein SS: Henoch-Schönlein purpura and recurrent renal failure. Ren Fail. 32:888–891. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Oni L and Sampath S: Childhood IgA vasculitis (Henoch Schonlein Purpura)-advances and knowledge gaps. Front Pediatr. 7(257)2019.PubMed/NCBI View Article : Google Scholar | |
|
Fan L, Yan H, Zhen X, Wu X, Hao J, Hou L and Han L: Safety and efficacy evaluation of traditional chinese medicine (Qingre-Lishi-Yishen Formula) based on treatment of regular glucocorticoid combined with cyclophosphamide pulse in children suffered from moderately Severe Henoch-Schonlein Purpura nephritis with nephrotic proteinuria. Evid Based Complement Alternat Med. 2020(3920735)2020.PubMed/NCBI View Article : Google Scholar | |
|
Nichols JA and Katiyar SK: Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res. 302:71–83. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Tong H, Song X, Sun X, Sun G and Du F: Immunomodulatory and antitumor activities of grape seed proanthocyanidins. J Agric Food Chem. 59:11543–1157. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Huang S, Yang N, Liu Y, Hu L, Zhao J, Gao J, Li Y, Li C, Zhang X and Huang T: Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling. Nutr Res. 32:530–536. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wen W, Lu J, Zhang K and Chen S: Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila). 1:554–561. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Wu L, Huang Z, Qin P, Yao Y, Meng X, Zou J, Zhu K and Ren G: Chemical characterization of a procyanidin-rich extract from sorghum bran and its effect on oxidative stress and tumor inhibition in vivo. J Agric Food Chem. 59:8609–8615. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Yang L, Xian D, Xiong X, Lai R, Song J and Zhong J: Proanthocyanidins against oxidative stress: From molecular mechanisms to clinical applications. Biomed Res Int. 2018(8584136)2018.PubMed/NCBI View Article : Google Scholar | |
|
Mantena SK and Katiyar SK: Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Radic Biol Med. 40:1603–1614. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Koudoufio M, Feldman F, Ahmarani L, Delvin E, Spahis S, Desjardins Y and Levy E: Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis. Sci Rep. 11(3878)2021.PubMed/NCBI View Article : Google Scholar | |
|
Baldivia DDS, Leite DF, Castro DTH, Campos JF, Santos UPD, Paredes-Gamero EJ, Carollo CA, Silva DB, de Picoli Souza K and Dos Santos EL: Evaluation of in vitro antioxidant and anticancer properties of the aqueous extract from the stem bark of stryphnodendron adstringens. Int J Mol Sci. 19(2432)2018.PubMed/NCBI View Article : Google Scholar | |
|
Alsharairi NA: Insights into the mechanisms of action of proanthocyanidins and anthocyanins in the treatment of nicotine-induced non-small cell lung cancer. Int J Mol Sci. 23(7905)2022.PubMed/NCBI View Article : Google Scholar | |
|
Lau KK, Suzuki H, Novak J and Wyatt RJ: Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol. 25:19–26. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Keskin N, Civilibal M, Elevli M, Koldas M, Duru NS and Ozturk H: Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura. Pediatr Nephrol. 26:1989–1993. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xu H, Jiang G, Shen H, Li W, Mao J and Pan Y: Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population. Rheumatol Int. 37:1909–1915. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Canpinar H, Ozaltin F, Bilginer Y, Bakkaloğlu A and Ozen S: Toll-like receptors 2 and 4 cell surface expression reflects endotoxin tolerance in Henoch-Schönlein purpura. Turk J Pediatr. 52:22–27. 2010.PubMed/NCBI | |
|
Donadio ME, Loiacono E, Peruzzi L, Amore A, Camilla R, Chiale F, Vergano L, Boido A, Conrieri M, Bianciotto M, et al: Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy. Pediatr Nephrol. 29:1545–1551. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Chang H, Zhang QY, Lin Y, Cheng N and Zhang SQ: Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with Henoch-Schönlein Purpura. Int J Clin Exp Med. 8:13532–13539. 2015.PubMed/NCBI | |
|
Chang H, Yu DS, Liu XQ, Zhang QY, Cheng N, Zhang SQ and Qu ZH: Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis. Exp Ther Med. 7:1703–1707. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Zhou L, Xu F, Chang C, Tao Y, Song L and Li X: Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 27:301–307. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F and Weil R: NF-κB: At the borders of autoimmunity and inflammation. Front Immunol. 12(716469)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H: Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct Target Ther. 5(209)2020.PubMed/NCBI View Article : Google Scholar | |
|
Oh H and Ghosh S: NF-κB: Roles and regulation in different CD4(+) T-cell subsets. Immunol Rev. 252:41–51. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Pandiyan P and Zhu J: Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine. 76:13–24. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Chang H, Lin Y, Lei K, Wang F, Zhang QQ and Zhang QY: Role of hypomethylation of suppressor of cytokine signaling in T helper 17 cell/regulatory T cell imbalance in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 21:38–44. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Li-Weber M, Giaisi M, Baumann S, Pálfi K and Krammer PH: NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol. 34:1111–1118. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Li YY, Li CR, Wang GB, Yang J and Zu Y: Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein purpura. Rheumatol Int. 32:3785–3792. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yang J, Li CR, Zu Y, Wang GB and Li YB: Role of regulatory T cells in pathogenesis of Henoch-Schonlein purpura in children. Zhonghua Er Ke Za Zhi. 44:411–414. 2006.PubMed/NCBI(In Chinese). | |
|
Gujer C, Sundling C, Seder RA, Karlsson Hedestam GB and Loré K: Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology. 134:257–269. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ohue Y and Nishikawa H: Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 110:2080–2089. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Adeegbe DO and Nishikawa H: Natural and induced T regulatory cells in cancer. Front Immunol. 4(190)2013.PubMed/NCBI View Article : Google Scholar | |
|
Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, Wang X, Chen X, Zheng W, Xu X, et al: Association of increased Treg and Th17 with pathogenesis of moyamoya disease. Sci Rep. 7(3071)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang CM, Luo Y, Wang YC and Sheng GY: Roles of follicular helper T cells and follicular regulatory T cells in pathogenesis of Henoch-Schönlein purpura in children. Zhongguo Dang Dai Er Ke Za Zhi. 17:1084–1087. 2015.PubMed/NCBI(In Chinese). | |
|
Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT and Chiang BL: Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann Rheum Dis. 63:1511–1513. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Yang YH, Huang YH, Lin YL, Wang LC, Chuang YH, Yu HH, Lin YT and Chiang BL: Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin Exp Immunol. 144:247–253. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC and Van Egmond M: New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Autoimmun Rev. 16:1246–1253. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wu JJ, Zhu YT and Hu YM: Mechanism of feedback regulation of neutrophil inflammation in Henoch-Schönlein purpura. Eur Rev Med Pharmacol Sci. 20:4277–4285. 2016.PubMed/NCBI | |
|
Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Schieber M and Chandel NS: ROS function in redox signaling and oxidative stress. Curr Biol. 24:R453–R462. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Cesselli D, Aleksova A, Sponga S, Cervellin C, Di Loreto C, Tell G and Beltrami AP: Cardiac cell senescence and redox signaling. Front Cardiovasc Med. 4(38)2017.PubMed/NCBI View Article : Google Scholar | |
|
Ciccarese F, Raimondi V, Sharova E, Silic-Benussi M and Ciminale V: Nanoparticles as tools to target redox homeostasis in cancer cells. Antioxidants (Basel). 9(211)2020.PubMed/NCBI View Article : Google Scholar | |
|
Nakai K and Tsuruta D: What are reactive oxygen species, free radicals, and oxidative stress in skin diseases? Int J Mol Sci. 22(10799)2021.PubMed/NCBI View Article : Google Scholar | |
|
Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, et al: Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 11(694)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Y and Pagano PJ: Microvascular NADPH oxidase in health and disease. Free Radic Biol Med. 109:33–47. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Schröder K: NADPH oxidases: Current aspects and tools. Redox Biol. 34(101512)2020.PubMed/NCBI View Article : Google Scholar | |
|
Murphy MP: How mitochondria produce reactive oxygen species. Biochem J. 417:1–13. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Arazi H, Eghbali E and Suzuki K: Creatine supplementation, physical exercise and oxidative stress markers: A review of the mechanisms and effectiveness. Nutrients. 13(869)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim YW, West XZ and Byzova TV: Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 91:323–328. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Salazar G: NADPH Oxidases and mitochondria in vascular senescence. Int J Mol Sci. 19(1327)2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, Dong Y, Xu DL, Jiang JY, Wu L, Ke RJ, Fang SH and Peng Y: Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 20:378–382. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Gurses D, Parlaz N, Bor-Kucukatay M, Kucukatay V and Erken G: Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura. Iran J Pediatr. 24:166–172. 2014.PubMed/NCBI | |
|
Ece A, Kelekçi S, Kocamaz H, Hekimoğlu A, Balik H, Yolbaş I and Erel O: Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol. 27:163–169. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Higashi Y, Maruhashi T, Noma K and Kihara Y: Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications. Trends Cardiovasc Med. 24:165–169. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Mai J, Virtue A, Shen J, Wang H and Yang XF: An evolving new paradigm: Endothelial cells-conditional innate immune cells. J Hematol Oncol. 6(61)2013.PubMed/NCBI View Article : Google Scholar | |
|
Hou X, Yang S and Yin J: Blocking the REDD1/TXNIP axis ameliorates LPS-induced vascular endothelial cell injury through repressing oxidative stress and apoptosis. Am J Physiol Cell Physiol. 316:C104–C110. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wu H, Wen Y, Yue C, Li X and Gao R: Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin a vasculitis nephritis. Dis Markers. 2020(5514145)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yuan P, Bo Y, Ming G, Wen-Jun F, Qin Z and Bo H: Apoptosis of human umbilical vein endothelial cells (HUVEC) induced by IgA1 isolated from Henoch-Schonlein purpura children. Asian Pac J Allergy Immunol. 32:34–38. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Montezano AC and Touyz RM: Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol. 110:87–94. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Elalfy MS, Elhenawy YI, Deifalla S, Hegazy M, Sabra A and Abdelaziz Y: Oxidant/antioxidant status in children and adolescents with immune thrombocytopenia (ITP) and the role of an adjuvant antioxidant therapy. Pediatr Blood Cancer. 62:830–837. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Carta S, Semino C, Sitia R and Rubartelli A: Dysregulated IL-1β secretion in autoinflammatory diseases: A matter of stress? Front Immunol. 8(345)2017.PubMed/NCBI View Article : Google Scholar | |
|
Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, Fishbein MC, Chen S, Lehman TJ, Sato K, et al: Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 51:508–521.e6. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Sugino H, Sawada Y and Nakamura M: IgA Vasculitis: Etiology, treatment, biomarkers and epigenetic changes. Int J Mol Sci. 22(7538)2021.PubMed/NCBI View Article : Google Scholar | |
|
Lavieri R, Piccioli P, Carta S, Delfino L, Castellani P and Rubartelli A: TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production. J Immunol. 192:5373–5381. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Gong L, Lei Y, Liu Y, Tan F, Li S, Wang X, Xu M, Cai W, Du B, Xu F, et al: Vaccarin prevents ox-LDL-induced HUVEC EndMT, inflammation and apoptosis by suppressing ROS/p38 MAPK signaling. Am J Transl Res. 11:2140–2154. 2019.PubMed/NCBI | |
|
Duan T, Du Y, Xing C, Wang HY and Wang RF: Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 13(812774)2022.PubMed/NCBI View Article : Google Scholar | |
|
Aluri J, Cooper MA and Schuettpelz LG: Toll-Like receptor signaling in the establishment and function of the immune system. Cells. 10(1374)2021.PubMed/NCBI View Article : Google Scholar | |
|
Vijay K: Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int Immunopharmacol. 59:391–412. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kuzmich NN, Sivak KV, Chubarev VN, Porozov YB, Savateeva-Lyubimova TN and Peri F: TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel). 5(34)2017.PubMed/NCBI View Article : Google Scholar | |
|
Yao C, Oh JH, Lee DH, Bae JS, Jin CL, Park CH and Chung JH: Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes. Int J Mol Med. 35:1443–1450. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Krishnan JS, KSelvarajoo K, Tsuchiya M, Lee G and Choi S: Toll-like receptor signal transduction. Exp Mol Med. 39:421–438. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Rong Z, Huang Y, Cai H, Chen M, Wang H, Liu G, Zhang Z and Wu J: Gut microbiota disorders promote inflammation and aggravate spinal cord injury through the TLR4/MyD88 signaling pathway. Front Nutr. 8(702659)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K and Akira S: TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 4:1144–1150. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Mills KH: TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 11:807–822. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Park HS, Jung HY, Park EY, Kim J, Lee WJ and Bae YS: Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 173:3589–3593. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Gill R, Tsung A and Billiar T: Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med. 48:1121–1132. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Rauf A, Imran M, Abu-Izneid T, Iahtisham-Ul-Haq Patel S, Pan X, Naz S, Sanches Silva A, Saeed F and Rasul Suleria HA: Proanthocyanidins: A comprehensive review. Biomed Pharmacother. 116(108999)2019.PubMed/NCBI View Article : Google Scholar | |
|
Bensa M, Glavnik V and Vovk I: Leaves of Invasive Plants-Japanese, bohemian and giant knotweed-the promising new nource of Flavan-3-ols and proanthocyanidins. Plants (Basel). 9(118)2020.PubMed/NCBI View Article : Google Scholar | |
|
González-Quilen C, Rodríguez-Gallego E, Beltrán-Debón R, Pinent M, Ardévol A, Blay MT and Terra X: Health-promoting properties of proanthocyanidins for intestinal dysfunction. Nutrients. 12(130)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li S, Xu M, Niu Q, Xu S, Ding Y, Yan Y, Guo S and Li F: Efficacy of procyanidins against in vivo cellular oxidative damage: A systematic review and meta-analysis. PLoS One. 10(e0139455)2015.PubMed/NCBI View Article : Google Scholar | |
|
Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S and Goel A: Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer. Carcinogenesis. 39:767–777. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Nawrot-Hadzik I, Matkowski A, Kubasiewicz-Ross P and Hadzik J: Proanthocyanidins and Flavan-3-ols in the prevention and treatment of periodontitis-immunomodulatory effects, animal and clinical Studies. Nutrients. 13(239)2021.PubMed/NCBI View Article : Google Scholar | |
|
Odai T, Terauchi M, Kato K, Hirose A and Miyasaka N: Effects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: A randomized, double-blind, placebo-controlled study. Nutrients. 11(2844)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang R, Kang X, Liu L, Wang X, Li H, Zhu J, Cao Y and Zhu H: Gut microbiota modulation by plant polyphenols in koi carp (Cyprinus carpio L.). Front Microbiol. 13(977292)2022.PubMed/NCBI View Article : Google Scholar | |
|
Suo H, Tian R, Li J, Zhang S, Cui Y, Li L and Sun B: Compositional characterization study on high-molecular-mass polymeric polyphenols in red wines by chemical degradation. Food Res Int. 123:440–449. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yuan L, Wang Q, Zhang S and Zhang L: Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment. Exp Ther Med. 15:3924–3928. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Park MK, Park JS, Cho ML, Oh HJ, Heo YJ, Woo YJ, Heo YM, Park MJ, Park HS, Park SH, et al: Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis. Immunol Lett. 135:50–58. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Jhun JY, Moon SJ, Yoon BY, Byun JK, Kim EK, Yang EJ, Ju JH, Hong YS, Min JK, Park SH, et al: Grape seed proanthocyanidin extract-mediated regulation of STAT3 proteins contributes to Treg differentiation and attenuates inflammation in a murine model of obesity-associated arthritis. PLoS One. 8(e78843)2013.PubMed/NCBI View Article : Google Scholar | |
|
Park IJ, Cha SY, Kang M, So YS, Go HG, Mun SP, Ryu KS and Jang HK: Effect of proanthocyanidin-rich extract from Pinus radiata bark on immune response of specific-pathogen-free White Leghorn chickens. Poult Sci. 90:977–982. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Min HK, Kim SM, Baek SY, Woo JW, Park JS, Cho ML, Lee J, Kwok SK, Kim SW and Park SH: Anthocyanin extracted from black soybean seed coats prevents autoimmune arthritis by suppressing the development of Th17 cells and synthesis of proinflammatory cytokines by such cells, via inhibition of NF-κB. PLoS One. 10(e0138201)2015.PubMed/NCBI View Article : Google Scholar | |
|
Takano F, Takata T, Yoshihara A, Nakamura Y, Arima Y and Ohta T: Aqueous extract of peanut skin and its main constituent procyanidin A1 suppress serum IgE and IgG1 levels in mice-immunized with ovalbumin. Biol Pharm Bull. 30:922–927. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Long M, Yang SH, Han JX, Li P, Zhang Y, Dong S, Chen X, Guo J, Wang J and He JB: The protective effect of grape-seed proanthocyanidin extract on oxidative damage induced by zearalenone in kunming mice liver. Int J Mol Sci. 17(808)2016.PubMed/NCBI View Article : Google Scholar | |
|
Han S, Gao H, Chen S, Wang Q, Li X, Du LJ, Li J, Luo YY, Li JX, Zhao LC, et al: Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells. Sci Rep. 9(15087)2019.PubMed/NCBI View Article : Google Scholar | |
|
Katiyar SK: Proanthocyanidins from grape seeds inhibit UV-radiation-induced immune suppression in mice: Detection and analysis of molecular and cellular targets. Photochem Photobiol. 91:156–162. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kim SH, Bang J, Son CN, Baek WK and Kim JM: Grape seed proanthocyanidin extract ameliorates murine autoimmune arthritis through regulation of TLR4/MyD88/NF-κB signaling pathway. Korean J Intern Med. 33:612–621. 2018.PubMed/NCBI View Article : Google Scholar | |
|
El-Shitany NA and Eid B: Proanthocyanidin protects against cisplatin-induced oxidative liver damage through inhibition of inflammation and NF-κβ/TLR-4 pathway. Environ Toxicol. 32:1952–1963. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mittal A, Elmets CA and Katiyar SK: Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: Relationship to decreased fat and lipid peroxidation. Carcinogenesis. 24:1379–1388. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Rodríguez RM, Colom-Pellicer M, Blanco J, Calvo E, Aragonès G and Mulero M: Grape-Seed procyanidin extract (GSPE) Seasonal-Dependent modulation of glucose and lipid metabolism in the liver of healthy F344 rats. Biomolecules. 12(839)2022.PubMed/NCBI View Article : Google Scholar | |
|
Sharma SD, Meeran SM and Katiyar SK: Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-kappaB signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther. 6:995–1005. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Divya SP, Wang X, Pratheeshkumar P, Son YO, Roy RV, Kim D, Dai J, Hitron JA, Wang L, Asha P, et al: Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NF-κB signaling pathways in SKH-1 mice skin. Toxicol Appl Pharmacol. 284:92–99. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ma X, Wang R, Yu S, Lu G, Yu Y and Jiang C: Anti-Inflammatory activity of oligomeric proanthocyanidins via inhibition of NF-κB and MAPK in LPS-Stimulated MAC-T Cells. J Microbiol Biotechnol. 30:1458–1466. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rajput SA, Sun L, Zhang NY, Khalil MM, Ling Z, Chong L, Wang S, Rajput IR, Bloch DM, Khan FA, et al: Grape seed proanthocyanidin extract alleviates aflatoxin B1-induced immunotoxicity and oxidative stress via modulation of NF-κB and Nrf2 signaling pathways in broilers. Toxins (Basel). 11(23)2019.PubMed/NCBI View Article : Google Scholar | |
|
Jia Z, Song Z, Zhao Y, Wang X and Liu P: Grape seed proanthocyanidin extract protects human lens epithelial cells from oxidative stress via reducing NF-кB and MAPK protein expression. Mol Vis. 17:210–217. 2011.PubMed/NCBI | |
|
Schmuch J, Beckert S, Brandt S, Löhr G, Hermann F, Schmidt TJ, Beikler T and Hensel A: Extract from Rumex acetosa L. for prophylaxis of periodontitis: Inhibition of bacterial in vitro adhesion and of gingipains of Porphyromonas gingivalis by epicatechin-3-O-(4β→8)-epicatechin-3-O-gallate (procyanidin-B2-Di-gallate). PLoS One. 10(e0120130)2015.PubMed/NCBI View Article : Google Scholar | |
|
Steffen Y, Gruber C, Schewe T and Sies H: Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys. 469:209–219. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Álvarez E, Rodiño-Janeiro BK, Jerez M, Ucieda-Somoza R, Núñez MJ and González-Juanatey JR: Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase. J Cell Biochem. 113:1386–1396. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Pinna C, Morazzoni P and Sala A: Proanthocyanidins from Vitis vinifera inhibit oxidative stress-induced vascular impairment in pulmonary arteries from diabetic rats. Phytomedicine. 25:39–44. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Weseler AR and Bast A: Masquelier's grape seed extract: From basic flavonoid research to a well-characterized food supplement with health benefits. Nutr J. 16(5)2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang LJ, Zhu DN, Dang YL and Zhao X: Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: Outcome and safety. Exp Ther Med. 11:2391–2394. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sano A: Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects. Food Chem Toxicol. 108:519–523. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Occhipinti A, Germano A and Maffei ME: Prevention of urinary tract infection with oximacro, a cranberry extract with a high content of A-type proanthocyanidins: A pre-clinical double-blind controlled study. Urol J. 13:2640–2649. 2016.PubMed/NCBI | |
|
Serrano J, Casanova-Martí À, Gil-Cardoso K, Blay MT, Terra X, Pinent M and Ardévol A: Acutely administered grape-seed proanthocyanidin extract acts as a satiating agent. Food Funct. 7:483–490. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhao Y, Xie Y, Li X, Song J, Guo M, Xian D and Zhong J: The protective effect of proanthocyanidins on the psoriasis-like cell models via PI3K/AKT and HO-1. Redox Rep. 27:200–211. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Omma A, Colak S, Can Sandikci S, Yucel C, Erden A, Sertoglu E and Ozgurtas T: Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura). Int J Rheum Dis. 22:1920–1925. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang B, Shao-Kuan FR and Dong C: Expression and significance of follicular helper T cells and galactose-deficient IgA1 in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 22:473–477. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Long M, Zhang Y, Li P, Yang SH, Zhang WK, Han JX, Wang Y and He JB: Intervention of Grape seed proanthocyanidin extract on the subchronic immune injury in mice induced by Aflatoxin B1. Int J Mol Sci. 17(516)2016.PubMed/NCBI View Article : Google Scholar | |
|
Liu X, Qiu J, Zhao S, You B, Ji X, Wang Y, Cui X, Wang Q and Gao H: Grape seed proanthocyanidin extract alleviates ouabain-induced vascular remodeling through regulation of endothelial function. Mol Med Rep. 6:949–954. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Di Pietro GM, Castellazzi ML, Mastrangelo A, Montini G, Marchisio P and Tagliabue C: Henoch-Schönlein Purpura in children: Not only kidney but also lung. Pediatr Rheumatol Online J. 17(75)2019.PubMed/NCBI View Article : Google Scholar | |
|
Padeh S and Passwell JH: Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin. Isr Med Assoc J. 2:482–483. 2000.PubMed/NCBI | |
|
Pan S and Zhong J: Construction and identification of simplified rat model of Henoch-Schönlein Purpura. Sichuan Med J. 42:669–672. 2021.(In Chinese). | |
|
Li Y, Feng X, Huang L, Zhu H, Xu Y, Sui X, Xu Y, Han Y and Qin C: Hematologic and immunological characteristics of Henoch-Schönlein purpura in rat and rabbit models induced with ovalbumin based on type III hypersensitivity. Sci Rep. 5(8862)2015.PubMed/NCBI View Article : Google Scholar | |
|
Kaegi C, Wuest B, Schreiner J, Steiner UC, Vultaggio A, Matucci A, Crowley C and Boyman O: Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders. Front Immunol. 10(1990)2019.PubMed/NCBI View Article : Google Scholar | |
|
Gohari A, Matsell DG, Mammen C and Goldman RD: Henoch-Schönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease. Can Fam Physician. 66:895–897. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Du Y, Hou L, Zhao C, Han M and Wu Y: Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol. 27:765–771. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Nikibakhsh AA, Mahmoodzadeh H, Karamyyar M, Hejazi S, Noroozi M, Macooie AA, Gholizadeh A and Gholizadeh L: Treatment of complicated henoch-schönlein purpura with mycophenolate mofetil: A retrospective case series report. Int J Rheumatol. 2010(254316)2010.PubMed/NCBI View Article : Google Scholar | |
|
Fujimoto M, Katayama K, Nishikawa K, Mizoguchi S, Oda K, Hirabayashi Y, Suzuki Y, Haruki A, Ito T, Murata T, et al: A Kidney transplant recipient with recurrent Henoch-Schönlein Purpura nephritis successfully treated with steroid pulse therapy and epipharyngeal abrasive therapy. Nephron. 144 (Suppl 1):S54–S48. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kurnia B: Henoch-Schonlein purpura in children: The role of corticosteroids. Open Access Maced J Med Sci. 7:1812–1814. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, et al: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 58:1607–1616. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Han F, Chen LL, Ren PP, Le JY, Choong PJ, Wang HJ, Xu Y and Chen JH: Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: A retrospective study. J Zhejiang Univ Sci B. 16:772–779. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Lu Z, Song J, Mao J, Xia Y and Wang C: Evaluation of mycophenolate mofetil and Low-dose steroid combined therapy in moderately severe Henoch-Schönlein Purpura nephritis. Med Sci Monit. 23:2333–2339. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hamilton P, Ogundare O, Raza A, Ponnusamy A, Gorton J, Alachkar H, Choudhury J, Barratt J and Kalra PA: Long-term therapeutic plasma exchange to prevent End-stage kidney disease in adult severe resistant Henoch-Schonlein purpura nephritis. Case Rep Nephrol. 2015(269895)2015.PubMed/NCBI View Article : Google Scholar |
